| protein dna complex disassembly | GO:0032986 | 1 | 1.000 | Human |
| nucleosome disassembly | GO:0006337 | 1 | 1.000 | Human |
| chromatin disassembly | GO:0031498 | 1 | 1.000 | Human |
| covalent chromatin modification | GO:0016569 | 163 | 1.000 | |
| regulation of transcription during meiosis | GO:0051037 | 1 | 1.000 | |
| chromatin modification | GO:0016568 | 187 | 1.000 | |
| chromatin organization | GO:0006325 | 206 | 1.000 | |
| histone modification | GO:0016570 | 159 | 0.999 | |
| histone h3 acetylation | GO:0043966 | 14 | 0.998 | |
| protein dna complex subunit organization | GO:0071824 | 28 | 0.998 | Human |
| blastocyst growth | GO:0001832 | 23 | 0.997 | |
| negative regulation of chromatin silencing | GO:0031936 | 1 | 0.996 | |
| regulation of chromatin silencing | GO:0031935 | 2 | 0.995 | |
| chromatin assembly or disassembly | GO:0006333 | 16 | 0.994 | Human |
| maintenance of chromatin silencing | GO:0006344 | 2 | 0.994 | |
| histone lysine methylation | GO:0034968 | 50 | 0.993 | |
| histone acetylation | GO:0016573 | 41 | 0.991 | |
| protein complex disassembly | GO:0043241 | 40 | 0.991 | Human |
| protein deacetylation | GO:0006476 | 32 | 0.991 | |
| positive regulation of dna templated transcription elongation | GO:0032786 | 2 | 0.989 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.989 | |
| positive regulation of transcription from rna polymerase ii promoter in response to stress | GO:0036003 | 3 | 0.988 | |
| methylation | GO:0032259 | 134 | 0.988 | |
| blastocyst development | GO:0001824 | 80 | 0.988 | |
| dna methylation | GO:0006306 | 43 | 0.987 | |
| histone h4 acetylation | GO:0043967 | 10 | 0.979 | |
| macromolecule deacylation | GO:0098732 | 37 | 0.976 | |
| histone deubiquitination | GO:0016578 | 2 | 0.971 | |
| stem cell fate specification | GO:0048866 | 3 | 0.971 | |
| internal peptidyl lysine acetylation | GO:0018393 | 42 | 0.970 | |
| positive regulation of transcription elongation from rna polymerase ii promoter | GO:0032968 | 2 | 0.969 | |
| neural tube development | GO:0021915 | 160 | 0.966 | |
| regionalization | GO:0003002 | 337 | 0.963 | |
| peptidyl lysine methylation | GO:0018022 | 29 | 0.962 | |
| regulation of protein deacetylation | GO:0090311 | 17 | 0.962 | |
| dna alkylation | GO:0006305 | 43 | 0.960 | |
| dna metabolic process | GO:0006259 | 303 | 0.955 | |
| histone h4 k16 acetylation | GO:0043984 | 3 | 0.953 | |
| camera type eye development | GO:0043010 | 266 | 0.953 | |
| dna methylation on cytosine | GO:0032776 | 5 | 0.952 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.952 | |
| dendrite development | GO:0016358 | 115 | 0.948 | |
| regulation of histone modification | GO:0031056 | 56 | 0.946 | |
| protein acylation | GO:0043543 | 64 | 0.943 | |
| internal protein amino acid acetylation | GO:0006475 | 42 | 0.943 | |
| regulation of cell cycle g2 m phase transition | GO:1902749 | 10 | 0.939 | |
| oligosaccharide catabolic process | GO:0009313 | 2 | 0.933 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.929 | |
| neuroblast fate commitment | GO:0014017 | 1 | 0.927 | |
| stem cell maintenance | GO:0019827 | 130 | 0.927 | |
| gonad development | GO:0008406 | 141 | 0.922 | Worm |
| histone h4 deacetylation | GO:0070933 | 4 | 0.917 | |
| cell fate commitment | GO:0045165 | 210 | 0.917 | |
| histone methylation | GO:0016571 | 71 | 0.912 | |
| heart morphogenesis | GO:0003007 | 178 | 0.912 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.911 | |
| regulation of chromatin modification | GO:1903308 | 57 | 0.906 | |
| histone deacetylation | GO:0016575 | 26 | 0.877 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.876 | |
| neuron projection guidance | GO:0097485 | 141 | 0.867 | |
| regulation of binding | GO:0051098 | 111 | 0.862 | |
| macromolecule methylation | GO:0043414 | 120 | 0.859 | |
| gonad morphogenesis | GO:0035262 | 1 | 0.855 | |
| protein deacylation | GO:0035601 | 36 | 0.854 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.853 | |
| blastocyst hatching | GO:0001835 | 4 | 0.853 | |
| protein methylation | GO:0006479 | 81 | 0.849 | |
| macromolecular complex disassembly | GO:0032984 | 43 | 0.841 | Human |
| regulation of chromatin organization | GO:1902275 | 57 | 0.837 | |
| posttranscriptional gene silencing | GO:0016441 | 10 | 0.834 | |
| single species biofilm formation | GO:0044010 | 1 | 0.834 | |
| epithelial tube formation | GO:0072175 | 130 | 0.832 | |
| dna modification | GO:0006304 | 50 | 0.830 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.830 | |
| axonogenesis | GO:0007409 | 274 | 0.824 | |
| negative regulation of gene expression epigenetic | GO:0045814 | 15 | 0.801 | |
| gene silencing | GO:0016458 | 38 | 0.801 | |
| definitive erythrocyte differentiation | GO:0060318 | 7 | 0.801 | |
| chromatin remodeling | GO:0006338 | 32 | 0.797 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.795 | |
| glial cell fate determination | GO:0007403 | 3 | 0.795 | |
| histone h3 k14 acetylation | GO:0044154 | 3 | 0.795 | |
| biofilm formation | GO:0042710 | 1 | 0.793 | |
| neural tube closure | GO:0001843 | 90 | 0.793 | |
| negative regulation of transcription from rna polymerase i promoter | GO:0016479 | 2 | 0.785 | |
| atp dependent chromatin remodeling | GO:0043044 | 9 | 0.780 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.774 | |
| neural tube formation | GO:0001841 | 108 | 0.767 | |
| neuroblast differentiation | GO:0014016 | 2 | 0.759 | |
| neuroblast proliferation | GO:0007405 | 49 | 0.758 | |
| cardiac chamber development | GO:0003205 | 108 | 0.758 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.747 | |
| chromatin silencing at rdna | GO:0000183 | 3 | 0.741 | |
| nucleosome positioning | GO:0016584 | 4 | 0.739 | |
| regulation of neuroblast proliferation | GO:1902692 | 27 | 0.734 | |
| histone h3 k4 trimethylation | GO:0080182 | 5 | 0.731 | |
| rhythmic process | GO:0048511 | 174 | 0.727 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.724 | |
| forebrain development | GO:0030900 | 302 | 0.724 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.705 | Worm |
| peptidyl lysine acetylation | GO:0018394 | 45 | 0.698 | |
| chromatin assembly | GO:0031497 | 13 | 0.696 | |
| stem cell differentiation | GO:0048863 | 268 | 0.678 | |
| cell fate determination | GO:0001709 | 32 | 0.657 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.654 | |
| interaction with symbiont | GO:0051702 | 14 | 0.646 | |
| positive regulation of chromatin binding | GO:0035563 | 3 | 0.646 | |
| epidermis development | GO:0008544 | 187 | 0.645 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.642 | |
| primary neural tube formation | GO:0014020 | 95 | 0.641 | |
| regulation of viral transcription | GO:0046782 | 3 | 0.627 | |
| chromatin remodeling at centromere | GO:0031055 | 2 | 0.618 | |
| positive regulation of binding | GO:0051099 | 49 | 0.610 | |
| peptidyl lysine trimethylation | GO:0018023 | 12 | 0.608 | |
| chromatin mediated maintenance of transcription | GO:0048096 | 2 | 0.607 | |
| male gamete generation | GO:0048232 | 285 | 0.604 | |
| glial cell differentiation | GO:0010001 | 131 | 0.600 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.599 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.587 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.577 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.576 | |
| germ cell development | GO:0007281 | 185 | 0.572 | |
| gland development | GO:0048732 | 330 | 0.569 | |
| negative regulation of gene silencing | GO:0060969 | 2 | 0.562 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.554 | |
| spermatogenesis | GO:0007283 | 284 | 0.552 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.537 | |
| regulation of transcription from rna polymerase ii promoter in response to stress | GO:0043618 | 8 | 0.525 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.517 | |
| nuclear division | GO:0000280 | 158 | 0.507 | |
| viral gene expression | GO:0019080 | 3 | 0.491 | |
| tube formation | GO:0035148 | 140 | 0.491 | |
| positive regulation of cell cycle g2 m phase transition | GO:1902751 | 5 | 0.485 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.483 | |
| histone h3 deacetylation | GO:0070932 | 8 | 0.482 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.477 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.475 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.457 | |
| blastocyst formation | GO:0001825 | 33 | 0.448 | |
| histone h4 k12 acetylation | GO:0043983 | 2 | 0.445 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 70 | 0.441 | |
| positive regulation of viral process | GO:0048524 | 5 | 0.441 | |
| regulation of transcription involved in g1 s transition of mitotic cell cycle | GO:0000083 | 3 | 0.433 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.418 | |
| male meiosis i | GO:0007141 | 16 | 0.417 | |
| protein alkylation | GO:0008213 | 81 | 0.411 | |
| mrna processing | GO:0006397 | 63 | 0.410 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.409 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.409 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.392 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.386 | |
| regulation of histone methylation | GO:0031060 | 30 | 0.380 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.379 | |
| regulation of dna templated transcription in response to stress | GO:0043620 | 9 | 0.375 | |
| cardiac right ventricle formation | GO:0003219 | 3 | 0.372 | |
| positive regulation of chromatin modification | GO:1903310 | 28 | 0.372 | |
| transcription elongation from rna polymerase ii promoter | GO:0006368 | 9 | 0.371 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.359 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.357 | |
| negative regulation of chromosome organization | GO:2001251 | 30 | 0.354 | |
| gene silencing by rna | GO:0031047 | 19 | 0.351 | |
| regulation of g1 s transition of mitotic cell cycle | GO:2000045 | 35 | 0.346 | |
| positive regulation of chromosome organization | GO:2001252 | 33 | 0.345 | |
| gene silencing by mirna | GO:0035195 | 10 | 0.339 | |
| cell cycle g2 m phase transition | GO:0044839 | 20 | 0.336 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.333 | |
| posttranscriptional gene silencing by rna | GO:0035194 | 10 | 0.330 | |
| rna interference | GO:0016246 | 2 | 0.325 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.321 | |
| organism emergence from protective structure | GO:0071684 | 4 | 0.309 | |
| modification by host of symbiont morphology or physiology | GO:0051851 | 12 | 0.302 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.301 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.298 | |
| hindbrain development | GO:0030902 | 128 | 0.295 | |
| heart field specification | GO:0003128 | 6 | 0.294 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.287 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.283 | |
| positive regulation of cell proliferation involved in heart valve morphogenesis | GO:0003251 | 1 | 0.281 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.281 | |
| lens development in camera type eye | GO:0002088 | 62 | 0.279 | |
| positive regulation of mitotic cell cycle phase transition | GO:1901992 | 17 | 0.278 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.278 | |
| regulation of stem cell proliferation | GO:0072091 | 78 | 0.277 | |
| viral life cycle | GO:0019058 | 36 | 0.277 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.272 | |
| dna templated transcription elongation | GO:0006354 | 13 | 0.272 | |
| genitalia development | GO:0048806 | 37 | 0.270 | Worm |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.269 | |
| regulation of androgen receptor signaling pathway | GO:0060765 | 3 | 0.262 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.262 | |
| meiosis i | GO:0007127 | 60 | 0.259 | |
| regulation of histone h3 k4 methylation | GO:0051569 | 12 | 0.252 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.248 | |
| thick ascending limb development | GO:0072023 | 2 | 0.248 | |
| mrna splicing via spliceosome | GO:0000398 | 43 | 0.245 | |
| receptor mediated endocytosis | GO:0006898 | 51 | 0.244 | Worm |
| regulation of sarcomere organization | GO:0060297 | 4 | 0.242 | |
| immunoglobulin secretion involved in immune response | GO:0002380 | 2 | 0.241 | |
| metanephric dct cell differentiation | GO:0072240 | 3 | 0.238 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.235 | |
| amine metabolic process | GO:0009308 | 45 | 0.234 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 40 | 0.233 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.232 | |
| epithalamus development | GO:0021538 | 2 | 0.230 | |
| glial cell fate commitment | GO:0021781 | 14 | 0.228 | |
| regulation of histone deacetylation | GO:0031063 | 12 | 0.225 | |
| positive regulation of g2 m transition of mitotic cell cycle | GO:0010971 | 5 | 0.225 | |
| inner cell mass cell proliferation | GO:0001833 | 15 | 0.224 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.224 | |
| negative regulation of stem cell proliferation | GO:2000647 | 12 | 0.223 | |
| lung development | GO:0030324 | 164 | 0.223 | |
| compound eye development | GO:0048749 | 1 | 0.220 | |
| positive regulation of cell fate commitment | GO:0010455 | 8 | 0.219 | |
| male meiosis | GO:0007140 | 37 | 0.217 | |
| circadian regulation of gene expression | GO:0032922 | 48 | 0.212 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.211 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.210 | |
| hepaticobiliary system development | GO:0061008 | 67 | 0.210 | |
| negative regulation of cell cycle phase transition | GO:1901988 | 48 | 0.208 | |
| negative regulation of androgen receptor signaling pathway | GO:0060766 | 3 | 0.207 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.204 | |
| organelle fission | GO:0048285 | 170 | 0.202 | |
| oocyte differentiation | GO:0009994 | 35 | 0.200 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.196 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.195 | |
| oligodendrocyte differentiation | GO:0048709 | 53 | 0.193 | |
| negative regulation of cell cycle process | GO:0010948 | 69 | 0.192 | |
| oogenesis | GO:0048477 | 56 | 0.189 | |
| neuroblast fate determination | GO:0007400 | 1 | 0.189 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.187 | |
| g1 s transition of mitotic cell cycle | GO:0000082 | 57 | 0.187 | |
| cardiac ventricle morphogenesis | GO:0003208 | 50 | 0.186 | |
| circadian rhythm | GO:0007623 | 114 | 0.185 | |
| endocytosis | GO:0006897 | 168 | 0.183 | Worm |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.181 | |
| stem cell development | GO:0048864 | 219 | 0.180 | |
| spermatid differentiation | GO:0048515 | 115 | 0.180 | |
| liver development | GO:0001889 | 66 | 0.178 | |
| limb morphogenesis | GO:0035108 | 149 | 0.177 | |
| positive regulation of gene silencing by mirna | GO:2000637 | 1 | 0.177 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.175 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.174 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.173 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.172 | |
| chromatin silencing | GO:0006342 | 15 | 0.171 | |
| chemotaxis | GO:0006935 | 247 | 0.167 | |
| heart trabecula morphogenesis | GO:0061384 | 26 | 0.166 | |
| negative regulation of neuron projection development | GO:0010977 | 50 | 0.166 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.164 | |
| regulation of peptidyl lysine acetylation | GO:2000756 | 22 | 0.162 | |
| dna methylation on cytosine within a cg sequence | GO:0010424 | 2 | 0.161 | |
| negative regulation of neural precursor cell proliferation | GO:2000178 | 18 | 0.158 | |
| negative regulation of cell cycle g1 s phase transition | GO:1902807 | 18 | 0.158 | |
| neurohypophysis development | GO:0021985 | 2 | 0.158 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.157 | |
| negative regulation of chromatin modification | GO:1903309 | 19 | 0.157 | |
| intracellular receptor signaling pathway | GO:0030522 | 74 | 0.155 | Human |
| negative regulation of g1 s transition of mitotic cell cycle | GO:2000134 | 18 | 0.154 | |
| regulation of rna splicing | GO:0043484 | 37 | 0.154 | |
| heart trabecula formation | GO:0060347 | 14 | 0.147 | |
| positive regulation of cell cycle process | GO:0090068 | 61 | 0.147 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.145 | |
| habituation | GO:0046959 | 3 | 0.143 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.142 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.141 | |
| negative regulation of growth | GO:0045926 | 99 | 0.140 | |
| proprioception | GO:0019230 | 4 | 0.139 | |
| regulation of schwann cell proliferation | GO:0010624 | 2 | 0.139 | |
| negative regulation of ras protein signal transduction | GO:0046580 | 18 | 0.136 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.133 | |
| memory | GO:0007613 | 58 | 0.132 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.132 | |
| regulation of cell division | GO:0051302 | 76 | 0.131 | |
| appendage development | GO:0048736 | 166 | 0.130 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.130 | |
| histone h3 k4 methylation | GO:0051568 | 23 | 0.129 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.128 | |
| muscle tissue development | GO:0060537 | 308 | 0.127 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.126 | |
| meiotic cell cycle process | GO:1903046 | 77 | 0.125 | |
| negative regulation of calcium ion dependent exocytosis | GO:0045955 | 3 | 0.125 | |
| palate development | GO:0060021 | 76 | 0.122 | |
| mrna transcription from rna polymerase ii promoter | GO:0042789 | 4 | 0.122 | |
| cell division | GO:0051301 | 120 | 0.122 | |
| regulation of response to dna damage stimulus | GO:2001020 | 34 | 0.122 | |
| modification of morphology or physiology of other organism | GO:0035821 | 18 | 0.121 | |
| respiratory tube development | GO:0030323 | 167 | 0.120 | |
| disaccharide metabolic process | GO:0005984 | 1 | 0.120 | |
| cell fate specification | GO:0001708 | 72 | 0.119 | |
| fungiform papilla morphogenesis | GO:0061197 | 5 | 0.118 | |
| negative regulation of circadian rhythm | GO:0042754 | 8 | 0.118 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.118 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.118 | |
| tube closure | GO:0060606 | 91 | 0.116 | |
| viral transcription | GO:0019083 | 3 | 0.116 | |
| phagocytosis | GO:0006909 | 66 | 0.116 | |
| regulation of gene silencing | GO:0060968 | 7 | 0.116 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 83 | 0.116 | |
| negative regulation of neuron differentiation | GO:0045665 | 101 | 0.113 | |
| endoderm development | GO:0007492 | 45 | 0.112 | |
| regulation of dna templated transcription elongation | GO:0032784 | 10 | 0.112 | |
| positive regulation of reproductive process | GO:2000243 | 19 | 0.111 | |
| lung cell differentiation | GO:0060479 | 30 | 0.111 | |
| negative regulation of cell morphogenesis involved in differentiation | GO:0010771 | 48 | 0.110 | |
| habenula development | GO:0021986 | 2 | 0.109 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.109 | |
| regulation of dna damage checkpoint | GO:2000001 | 3 | 0.107 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.103 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.103 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.100 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.099 | |
| blastoderm segmentation | GO:0007350 | 13 | 0.098 | |
| embryonic digestive tract development | GO:0048566 | 27 | 0.097 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.097 | |
| oocyte axis specification | GO:0007309 | 2 | 0.097 | |
| modification of morphology or physiology of other organism involved in symbiotic interaction | GO:0051817 | 16 | 0.097 | |
| dna conformation change | GO:0071103 | 37 | 0.096 | |
| negative regulation of neuroblast proliferation | GO:0007406 | 7 | 0.096 | |
| negative regulation of cell projection organization | GO:0031345 | 56 | 0.095 | |
| segmentation | GO:0035282 | 93 | 0.093 | |
| rna processing | GO:0006396 | 105 | 0.093 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.092 | |
| muscle cell development | GO:0055001 | 133 | 0.092 | |
| viral process | GO:0016032 | 41 | 0.091 | |
| maternal determination of anterior posterior axis embryo | GO:0008358 | 2 | 0.090 | |
| receptor biosynthetic process | GO:0032800 | 3 | 0.090 | |
| germ cell migration | GO:0008354 | 8 | 0.090 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.090 | |
| regulation of asymmetric cell division | GO:0009786 | 4 | 0.090 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.089 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.088 | |
| somitogenesis | GO:0001756 | 69 | 0.087 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.087 | |
| dna packaging | GO:0006323 | 30 | 0.086 | |
| epithelial cell development | GO:0002064 | 159 | 0.085 | |
| limb development | GO:0060173 | 166 | 0.085 | |
| regulation of dna dependent dna replication initiation | GO:0030174 | 3 | 0.085 | |
| erbb signaling pathway | GO:0038127 | 32 | 0.085 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.085 | |
| cell cycle g1 s phase transition | GO:0044843 | 57 | 0.083 | |
| embryonic camera type eye development | GO:0031076 | 36 | 0.083 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.082 | |
| positive regulation of dendrite development | GO:1900006 | 21 | 0.082 | |
| embryonic axis specification | GO:0000578 | 30 | 0.082 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.082 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.082 | |
| regulation of cell cycle g1 s phase transition | GO:1902806 | 35 | 0.082 | |
| germ line stem cell division | GO:0042078 | 2 | 0.081 | |
| artery development | GO:0060840 | 53 | 0.081 | |
| regulation of defense response | GO:0031347 | 233 | 0.080 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.079 | |
| regulation of bmp signaling pathway | GO:0030510 | 60 | 0.078 | |
| multi organism metabolic process | GO:0044033 | 7 | 0.078 | |
| dna methylation involved in gamete generation | GO:0043046 | 15 | 0.077 | |
| positive regulation of synaptic growth at neuromuscular junction | GO:0045887 | 1 | 0.076 | |
| ectodermal cell differentiation | GO:0010668 | 3 | 0.076 | |
| digestive system development | GO:0055123 | 200 | 0.075 | |
| cell proliferation involved in heart valve morphogenesis | GO:0003249 | 1 | 0.074 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.073 | |
| learning or memory | GO:0007611 | 148 | 0.072 | |
| heterochromatin assembly | GO:0031507 | 2 | 0.071 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.070 | |
| regulation of cell motility | GO:2000145 | 236 | 0.069 | |
| g2 m transition of mitotic cell cycle | GO:0000086 | 20 | 0.069 | |
| carbohydrate catabolic process | GO:0016052 | 32 | 0.069 | |
| placenta development | GO:0001890 | 140 | 0.068 | |
| white fat cell differentiation | GO:0050872 | 15 | 0.068 | |
| lung epithelium development | GO:0060428 | 37 | 0.068 | |
| dna repair | GO:0006281 | 107 | 0.067 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.067 | |
| stem cell fate commitment | GO:0048865 | 5 | 0.066 | |
| adult behavior | GO:0030534 | 135 | 0.066 | |
| trophectodermal cell differentiation | GO:0001829 | 21 | 0.065 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.065 | |
| regulation of symbiosis encompassing mutualism through parasitism | GO:0043903 | 52 | 0.065 | |
| histone lysine demethylation | GO:0070076 | 13 | 0.065 | |
| skin development | GO:0043588 | 220 | 0.065 | |
| negative regulation of canonical wnt signaling pathway | GO:0090090 | 51 | 0.064 | |
| inner cell mass cell differentiation | GO:0001826 | 7 | 0.064 | |
| secondary heart field specification | GO:0003139 | 6 | 0.063 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.063 | |
| i kappab kinase nf kappab signaling | GO:0007249 | 85 | 0.063 | |
| histone h3 k9 dimethylation | GO:0036123 | 4 | 0.062 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.062 | |
| regulation of meiotic cell cycle | GO:0051445 | 34 | 0.061 | |
| response to sterol | GO:0036314 | 4 | 0.061 | |
| negative regulation of proteasomal ubiquitin dependent protein catabolic process | GO:0032435 | 15 | 0.061 | |
| ascending thin limb development | GO:0072021 | 2 | 0.061 | |
| schwann cell proliferation | GO:0014010 | 2 | 0.061 | |
| negative regulation of bmp signaling pathway | GO:0030514 | 35 | 0.061 | |
| cellular respiration | GO:0045333 | 38 | 0.060 | |
| response to alcohol | GO:0097305 | 48 | 0.059 | |
| molting cycle | GO:0042303 | 90 | 0.059 | |
| zygotic determination of anterior posterior axis embryo | GO:0007354 | 3 | 0.059 | |
| mesodermal cell fate commitment | GO:0001710 | 17 | 0.059 | |
| immune effector process | GO:0002252 | 321 | 0.058 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.058 | |
| positive regulation of myeloid cell differentiation | GO:0045639 | 43 | 0.057 | |
| forebrain neuron fate commitment | GO:0021877 | 13 | 0.057 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.057 | |
| forebrain generation of neurons | GO:0021872 | 63 | 0.056 | |
| cd4 positive cd25 positive alpha beta regulatory t cell differentiation | GO:0002361 | 4 | 0.056 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.056 | |
| oocyte construction | GO:0007308 | 2 | 0.056 | |
| regulation of antimicrobial humoral response | GO:0002759 | 3 | 0.056 | |
| formation of anatomical boundary | GO:0048859 | 6 | 0.056 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.055 | |
| ventricular compact myocardium morphogenesis | GO:0003223 | 2 | 0.055 | |
| somatic stem cell maintenance | GO:0035019 | 47 | 0.055 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.055 | |
| skeletal system development | GO:0001501 | 356 | 0.054 | |
| positive regulation of wnt signaling pathway | GO:0030177 | 45 | 0.054 | |
| cardiac muscle cell development | GO:0055013 | 39 | 0.054 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.054 | |
| mrna metabolic process | GO:0016071 | 84 | 0.054 | |
| regulation of mrna processing | GO:0050684 | 41 | 0.054 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.053 | |
| positive regulation of mitotic sister chromatid separation | GO:1901970 | 2 | 0.053 | |
| dna recombination | GO:0006310 | 92 | 0.053 | |
| positive regulation of histone h3 k9 methylation | GO:0051574 | 4 | 0.053 | |
| embryonic digestive tract morphogenesis | GO:0048557 | 17 | 0.053 | |
| endocardial cell differentiation | GO:0060956 | 4 | 0.053 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.052 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.052 | |
| specification of organ identity | GO:0010092 | 30 | 0.052 | |
| somite development | GO:0061053 | 81 | 0.052 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 58 | 0.052 | |
| circulatory system process | GO:0003013 | 197 | 0.052 | |
| gliogenesis | GO:0042063 | 141 | 0.051 | |
| forebrain neuron differentiation | GO:0021879 | 52 | 0.051 | |
| regulation of dna binding | GO:0051101 | 39 | 0.051 | |
| telencephalon development | GO:0021537 | 186 | 0.051 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.050 | |
| cardiac muscle tissue growth | GO:0055017 | 37 | 0.050 | |
| mrna transcription | GO:0009299 | 4 | 0.050 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.050 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.049 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.049 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.049 | |
| neural retina development | GO:0003407 | 41 | 0.049 | |
| cellular response to lipid | GO:0071396 | 145 | 0.049 | |
| negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090101 | 61 | 0.048 | |
| mesoderm development | GO:0007498 | 100 | 0.048 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.048 | |
| inner cell mass cell fate commitment | GO:0001827 | 2 | 0.048 | |
| organ growth | GO:0035265 | 117 | 0.048 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.047 | |
| embryonic eye morphogenesis | GO:0048048 | 29 | 0.047 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.047 | |
| regulation of gene silencing by rna | GO:0060966 | 5 | 0.047 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.047 | |
| positive regulation of posttranscriptional gene silencing | GO:0060148 | 1 | 0.046 | |
| diencephalon development | GO:0021536 | 63 | 0.046 | |
| cartilage development | GO:0051216 | 140 | 0.046 | |
| metanephric mesenchyme morphogenesis | GO:0072133 | 4 | 0.046 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.046 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.046 | |
| actin filament based movement | GO:0030048 | 23 | 0.046 | |
| positive regulation of protein deacetylation | GO:0090312 | 9 | 0.046 | |
| negative regulation of protein catabolic process | GO:0042177 | 36 | 0.045 | |
| positive regulation of mitotic cell cycle | GO:0045931 | 41 | 0.045 | |
| kidney mesenchyme morphogenesis | GO:0072131 | 4 | 0.045 | |
| regulation of cellular protein catabolic process | GO:1903362 | 61 | 0.044 | |
| stem cell proliferation | GO:0072089 | 117 | 0.044 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.044 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.044 | |
| regulation of cardiac muscle cell proliferation | GO:0060043 | 23 | 0.043 | |
| dna integrity checkpoint | GO:0031570 | 28 | 0.043 | |
| regulation of myeloid leukocyte differentiation | GO:0002761 | 58 | 0.043 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.043 | |
| negative regulation of wnt signaling pathway | GO:0030178 | 73 | 0.043 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.043 | |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 45 | 0.043 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.043 | |
| negative regulation of dna demethylation | GO:1901536 | 2 | 0.042 | |
| oligosaccharide metabolic process | GO:0009311 | 11 | 0.042 | |
| rhombomere morphogenesis | GO:0021593 | 2 | 0.042 | |
| spermatid development | GO:0007286 | 108 | 0.042 | |
| negative regulation of cellular protein catabolic process | GO:1903363 | 22 | 0.042 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 57 | 0.041 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.041 | |
| endocrine system development | GO:0035270 | 98 | 0.041 | |
| lung epithelial cell differentiation | GO:0060487 | 29 | 0.040 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 58 | 0.040 | |
| regulation of organ growth | GO:0046620 | 61 | 0.039 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.039 | |
| regulation of protein stability | GO:0031647 | 52 | 0.039 | |
| negative regulation of fat cell differentiation | GO:0045599 | 36 | 0.039 | |
| intracellular steroid hormone receptor signaling pathway | GO:0030518 | 29 | 0.038 | Human |
